Loading…
Based on limited metadata, this warning letter was issued to Cosmax USA, Inc., a drug manufacturer, on October 15, 2020. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from the available information. The warning falls under FDA's drug product regulation and enforcement authority. Additional documentation would be needed to identify the specific compliance issues that prompted this enforcement action.